A Study to Evaluate the Drug Levels of Mezigdomide in Adult Participants With Renal Impairment

Status:
COMPLETED

Trial end date:
2024-11-15

Target enrollment:

Participant gender:

The purpose of this study is to evaluate the drug levels of mezigdomide in participants with renal impairment.

PHASE1

Celgene